{
    "clinical_study": {
        "@rank": "156514", 
        "acronym": "EU-CERT-ICD", 
        "arm_group": [
            {
                "arm_group_label": "ICD Group (n=1500)", 
                "description": "First ICD device implantation (after baseline assessments) is not part of this observational study and is carried out in the responsibility of the treating physician, all ICD-devices will undergo unique standard programming to ensure comparability of ICD shock events between patients."
            }, 
            {
                "arm_group_label": "Control Group (n=750)", 
                "description": "Patients who fulfill inclusion criteria but do not receive an ICD device will be followed as part of the Control Group"
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood sample for genetic analysis"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The \"EUropean Comparative Effectiveness Research to assess the use of primary prophylacTic\n      Implantable Cardioverter Defibrillators (EU-CERT-ICD)\" is a modular research project to\n      study the effectiveness of prophylactic ICDs in a prospective study, a retrospective\n      registry, and meta-analyses of existing evidence on the subject."
        }, 
        "brief_title": "Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Artery Disease", 
            "Myocardial Infarction", 
            "Dilated Cardiomyopathy", 
            "Implantable Defibrillator User"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiomyopathy, Dilated", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Infarction", 
                "Myocardial Infarction", 
                "Cardiomyopathies"
            ]
        }, 
        "detailed_description": {
            "textblock": "The prospective study part is an observational, prospective multi-centre study which aims to\n      enrol 2500 patients with ischemic or dilated cardiomyopathy and primary prophylactic ICD\n      indication for reduced left ventricular ejection fraction (LVEF) according to current\n      guidelines. According to the treating physician's decision and preference which is\n      independent from study participation, patients are recruited into one of two groups:\n      patients directly prior to first ICD implantation (ICD Group), or patients who are not\n      considered for prophylactic ICD treatment by the physician or are considered but refuse ICD\n      treatment (Control Group). Patients will undergo simple 12-lead electrocardiogram (ECG) and\n      Holter ECG diagnostics at baseline as well as genetic biobanking at entry to the study.  All\n      patients will be subsequently followed for at least 1 year and up to 4 years. Co-primary\n      endpoints are all-cause mortality and appropriate ICD shocks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ischemic or dilated cardiomyopathy and recommendation for primary prophylactic ICD\n             treatment following current international treatment guidelines\n\n          -  Written informed consent\n\n          -  If ICD implantation is planned, enrollment and study baseline testing needs to be\n             completed before de-novo ICD implantation\n\n        Exclusion Criteria:\n\n          -  Permanent atrial fibrillation or atrial fibrillation at baseline in case more than\n             15% of such patients at a given time have been enrolled\n\n          -  Indication for secondary prophylactic ICD treatment\n\n          -  Indication or candidate for cardiac resynchronization therapy\n\n          -  AV block II\u00b0-III\u00b0 at resting heart rates\n\n          -  Implanted pacemaker\n\n          -  Unstable cardiac disease such as decompensated heart failure (NYHA functional class\n             IV) or acute coronary syndrome\n\n          -  Participation in other clinical trials which exclude enrolment in other trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients who are eligible for primary prophylactic ICD implantation and potentially\n        eligible for study participation will be identified based on echocardiographic and/or 12\n        lead ECG results. For ICD Group patients, screening will be shortly before scheduled ICD\n        implantation. For Control Group patients, the time span between primary diagnosis of\n        eligibility for primary ICD implantation and the date of the primary diagnosis of\n        cardiomyopathy must be recorded in the eCRF, together with how and when the decision not\n        to prescribe a defibrillator was reached. Control group will be recruited from patients\n        with ischemic or dilated cardiomyopathies and LVEF \u2264 35%. Patients scheduled for ICD\n        implantation (ICD Group) undergo screening and baseline assessments prior to ICD\n        implantation. Patients for the Control Group will undergo baseline assessments as soon as\n        possible after screening. Baseline assessments are identical for the ICD Group and the\n        Control Group."
            }
        }, 
        "enrollment": {
            "#text": "2500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064192", 
            "org_study_id": "EU 602299"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "defibrillator, implantable cardioverter", 
            "sudden cardiac death", 
            "primary prophylaxis", 
            "risk stratification"
        ], 
        "lastchanged_date": "June 1, 2014", 
        "link": {
            "description": "EU-CERT-ICD Website", 
            "url": "http://www.eu-cert-icd.eu"
        }, 
        "location": [
            {
                "contact": {
                    "email": "rik.willems@med.kuleuven.be", 
                    "last_name": "Rik Willems, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "KU Leuven, Div. of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Rik Willems, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "robert.bernat@magdalena.hr", 
                    "last_name": "Robert Bernat, MD, PhD", 
                    "phone": "+38 54 9244 115"
                }, 
                "facility": {
                    "address": {
                        "city": "Krapinske Toplice", 
                        "country": "Croatia", 
                        "zip": "49217"
                    }, 
                    "name": "Magdalena Clinic"
                }, 
                "investigator": {
                    "last_name": "Janko Szavits-Nossan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jesper.hastrup.svendsen@rh.regionh.dk", 
                    "last_name": "Jesper Hastrup Svendsen, MD", 
                    "phone": "+45 3545 2735"
                }, 
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Rigshospitalet, Div. of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Jesper Hastrup Svendsen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "heikki.huikuri@oulu.fi", 
                    "last_name": "Heikki V Huikuri, MD", 
                    "phone": "+ 35 88 3154108"
                }, 
                "facility": {
                    "address": {
                        "city": "Oulu", 
                        "country": "Finland", 
                        "zip": "90014"
                    }, 
                    "name": "Department of Internal Medicine, University of Oulu"
                }, 
                "investigator": {
                    "last_name": "Heikki V Huikuri, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10117"
                    }, 
                    "name": "Charit\u00e9Centrum 1 Health and Human Sciences, Institute for Social Medicine, Epidemiology and Health Economics"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "markus.zabel@med.uni-goettingen.de", 
                    "last_name": "Markus Zabel, MD", 
                    "phone": "+49 551 3910265"
                }, 
                "facility": {
                    "address": {
                        "city": "Goettingen", 
                        "country": "Germany", 
                        "zip": "37075"
                    }, 
                    "name": "University Medical Center, Div. of Cardiology"
                }, 
                "investigator": [
                    {
                        "last_name": "Lars Luethje, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Pascal Munoz, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Leonard Bergau, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Markus Zabel, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Christian Sohns, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "stefan.kaab@med.uni-muenchen.de", 
                    "last_name": "Stefan K\u00e4\u00e4b, MD", 
                    "phone": "+49-89-7095-6159"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "81377"
                    }, 
                    "name": "Ludwig-Maximilians-University, Div. of Cardiology"
                }, 
                "investigator": [
                    {
                        "last_name": "Stefan Kaab, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Moritz F Sinner, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Axel Bauer, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "gschmidt@tum.de", 
                    "last_name": "Georg Schmidt, MD", 
                    "phone": "+49 89 4140 2352"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80636"
                    }, 
                    "name": "Department of Cardiovascular Diseases, German Heart Centre Munich, Technische Universit\u00e4t M\u00fcnchen"
                }, 
                "investigator": {
                    "last_name": "Georg Schmidt, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "christine.zuern@med.uni-tuebingen.de", 
                    "last_name": "Christine S Zuern, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tuebingen", 
                        "country": "Germany", 
                        "zip": "72076"
                    }, 
                    "name": "University Hospital Tuebingen, Div. of Cardiology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pflevari@yahoo.com", 
                    "last_name": "Panagiota Flevari, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Athens", 
                        "country": "Greece"
                    }, 
                    "name": "Attikon University Hospital, Div. of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Panagiota Flevari, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "merkely.bela@kardio.sote.hu", 
                    "last_name": "B\u00e9la Merkely, MD, PhD, DSc", 
                    "phone": "+36 1 458 6810"
                }, 
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1122"
                    }, 
                    "name": "Semmelweis University Heart and Vascular Center"
                }, 
                "investigator": [
                    {
                        "last_name": "B\u00e9la Merkely, MD, PhD, DSc", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "G\u00e1bor Sz\u00e9plaki, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "m.a.vos@umcutrecht.nl", 
                    "last_name": "Marc A Vos, PhD", 
                    "phone": "+31 30 253 8900"
                }, 
                "contact_backup": {
                    "last_name": "Jeannette Visser-Bouman, RN", 
                    "phone": "+31 88 7559433"
                }, 
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3584"
                    }, 
                    "name": "Universitair Medisch Centrum Utrecht, Dept. of Physiology & Cardiology"
                }, 
                "investigator": [
                    {
                        "last_name": "Marc A Vos, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Anton E Tuinenburg, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "lubinski.a@gmail.com", 
                    "last_name": "Andrzej Lubinski, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lodz", 
                        "country": "Poland"
                    }, 
                    "name": "Medical University of Lodz"
                }, 
                "investigator": {
                    "last_name": "Andrzej Lubinski, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "robert.hatala@nusch.sk", 
                    "last_name": "Robert Hatala, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bratislava", 
                        "country": "Slovakia"
                    }, 
                    "name": "Slovak Medical University, Heart Center"
                }, 
                "investigator": {
                    "last_name": "Robert Hatala, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jbrugada@clinic.ub.es", 
                    "last_name": "Josep Brugada, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Cl\u00ednic, Universitat de Barcelona"
                }, 
                "investigator": [
                    {
                        "last_name": "Josep Brugada, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Elena Arbelo, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "frieder.braunschweig@karolinska.se", 
                    "last_name": "Frieder Braunschweig, MD, PhD", 
                    "phone": "+46-8-51771629"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "17176"
                    }, 
                    "name": "Karolinska Institute, Div. of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Frieder Braunschweig, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "csticherling@uhbs.ch", 
                    "last_name": "Christian Sticherling, MD", 
                    "phone": "+41-61-556 5817"
                }, 
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "4031"
                    }, 
                    "name": "University Hospital Basel, Div. of Cardiology"
                }, 
                "investigator": {
                    "last_name": "Christian Sticherling, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "state": "Purley, Surrey", 
                        "zip": "CR8 3NQ"
                    }, 
                    "name": "St. Paul's Cardiac Electrophysiology"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Croatia", 
                "Denmark", 
                "Finland", 
                "Germany", 
                "Greece", 
                "Hungary", 
                "Netherlands", 
                "Poland", 
                "Slovakia", 
                "Spain", 
                "Sweden", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "2", 
        "official_title": "Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe", 
        "overall_contact": {
            "email": "leonard.bergau@med.uni-goettingen.de", 
            "last_name": "Leonard Bergau, MD", 
            "phone": "+49 551 3910265"
        }, 
        "overall_contact_backup": {
            "email": "pascal.munoz@med.uni-goettingen.de", 
            "last_name": "Pascal Munoz, MD", 
            "phone": "+49 551 399954"
        }, 
        "overall_official": {
            "affiliation": "University Medical Center Goettingen", 
            "last_name": "Markus Zabel, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Institutional Review Board", 
                "All Other Countries: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Co-Primary Endpoint", 
                "measure": "All-Cause Mortality", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "Co-Primary Endpoint", 
                "measure": "First Appropriate ICD Shock", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }
        ], 
        "reference": [
            {
                "PMID": "22796257", 
                "citation": "Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K, Goff DC, Hirsch AT, Hylek EM, Peterson ED, Roger VL, Selby JV, Udelson JE, Lauer MS. Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2012 Aug 14;60(7):569-80. doi: 10.1016/j.jacc.2011.12.057. Epub 2012 Jul 11."
            }, 
            {
                "PMID": "11794197", 
                "citation": "Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001 Nov 15;345(20):1473-82. Review. No abstract available."
            }, 
            {
                "PMID": "15659722", 
                "citation": "Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005 Jan 20;352(3):225-37."
            }, 
            {
                "PMID": "18391108", 
                "citation": "Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation. 2008 Apr 15;117(15):1918-26. Epub 2008 Apr 7."
            }, 
            {
                "PMID": "18804736", 
                "citation": "Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21. doi: 10.1016/j.jacc.2008.05.058. Review."
            }, 
            {
                "PMID": "23131066", 
                "citation": "Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012 Dec 13;367(24):2275-83. doi: 10.1056/NEJMoa1211107. Epub 2012 Nov 6."
            }, 
            {
                "PMID": "22312139", 
                "citation": "MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Calzavara AJ, Austin PC, Tu JV, Lee DS. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med. 2012 Feb 7;156(3):195-203. doi: 10.7326/0003-4819-156-3-201202070-00007."
            }, 
            {
                "PMID": "19359333", 
                "citation": "Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace. 2009 Jun;11(6):716-26. doi: 10.1093/europace/eup068. Epub 2009 Apr 9."
            }, 
            {
                "PMID": "21893137", 
                "citation": "Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm. 2012 Jan;9(1):42-6. doi: 10.1016/j.hrthm.2011.08.031. Epub 2011 Sep 3."
            }, 
            {
                "PMID": "23280225", 
                "citation": "Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA. 2013 Jan 2;309(1):55-62. doi: 10.1001/jama.2012.157182."
            }, 
            {
                "PMID": "10227219", 
                "citation": "Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schomig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999 Apr 24;353(9162):1390-6."
            }, 
            {
                "PMID": "16714188", 
                "citation": "Bauer A, Kantelhardt JW, Barthel P, Schneider R, M\u00e4kikallio T, Ulm K, Hnatkova K, Sch\u00f6mig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006 May 20;367(9523):1674-81."
            }, 
            {
                "PMID": "11877356", 
                "citation": "Zabel M, Malik M, Hnatkova K, Papademetriou V, Pittaras A, Fletcher RD, Franz MR. Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans. Circulation. 2002 Mar 5;105(9):1066-70."
            }, 
            {
                "PMID": "16979017", 
                "citation": "Thomsen MB, Volders PG, Beekman JD, Matz J, Vos MA. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol. 2006 Sep 19;48(6):1268-76. Epub 2006 Aug 28."
            }, 
            {
                "PMID": "18068035", 
                "citation": "Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol. 2007 Dec 11;50(24):2275-84. Epub 2007 Nov 26."
            }, 
            {
                "PMID": "22544366", 
                "citation": "Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, M\u00fcller-Nurasyid M, Krijthe BP, Lubitz SA, Bis JC, Chung MK, D\u00f6rr M, Ozaki K, Roberts JD, Smith JG, Pfeufer A, Sinner MF, Lohman K, Ding J, Smith NL, Smith JD, Rienstra M, Rice KM, Van Wagoner DR, Magnani JW, Wakili R, Clauss S, Rotter JI, Steinbeck G, Launer LJ, Davies RW, Borkovich M, Harris TB, Lin H, V\u00f6lker U, V\u00f6lzke H, Milan DJ, Hofman A, Boerwinkle E, Chen LY, Soliman EZ, Voight BF, Li G, Chakravarti A, Kubo M, Tedrow UB, Rose LM, Ridker PM, Conen D, Tsunoda T, Furukawa T, Sotoodehnia N, Xu S, Kamatani N, Levy D, Nakamura Y, Parvez B, Mahida S, Furie KL, Rosand J, Muhammad R, Psaty BM, Meitinger T, Perz S, Wichmann HE, Witteman JC, Kao WH, Kathiresan S, Roden DM, Uitterlinden AG, Rivadeneira F, McKnight B, Sj\u00f6gren M, Newman AB, Liu Y, Gollob MH, Melander O, Tanaka T, Stricker BH, Felix SB, Alonso A, Darbar D, Barnard J, Chasman DI, Heckbert SR, Benjamin EJ, Gudnason V, K\u00e4\u00e4b S. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012 Apr 29;44(6):670-5. doi: 10.1038/ng.2261."
            }, 
            {
                "PMID": "22117037", 
                "citation": "Seegers J, Vos MA, Flevari P, Willems R, Sohns C, Vollmann D, L\u00fcthje L, Kremastinos DT, Flor\u00e9 V, Meine M, Tuinenburg A, Myles RC, Simon D, Brockm\u00f6ller J, Friede T, Hasenfu\u00df G, Lehnart SE, Zabel M; EUTrigTreat Clinical Study Investigators. Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace. 2012 Mar;14(3):416-22. doi: 10.1093/europace/eur352. Epub 2011 Nov 23."
            }, 
            {
                "PMID": "23021332", 
                "citation": "Buxton AE. Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit. J Am Coll Cardiol. 2012 Oct 23;60(17):1656-8. doi: 10.1016/j.jacc.2012.06.041. Epub 2012 Sep 26."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064192"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Medical Center Goettingen", 
            "investigator_full_name": "Markus Zabel", 
            "investigator_title": "Associate Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time to First Inappropriate Shock", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "measure": "Sudden Cardiac Death", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "measure": "Cardiac Death", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "measure": "Non-Cardiac Death", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "presumed arrhythmogenic syncopes (per the judgment of each investigator and the endpoint committee)", 
                "measure": "Arrhythmogenic Syncope", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "successful resuscitation for ventricular tachyarrhythmias (especially in the non ICD Control Group)", 
                "measure": "Resuscitation", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "any ICD shock (appropriate or inappropriate)", 
                "measure": "Any ICD Shock", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "atrial fibrillation (if documented), defined as an atrial tachyarrhythmia >250 beats per minute (bpm) lasting at least 30 seconds is considered as secondary endpoint", 
                "measure": "Atrial Fibrillation", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "quality of life (QoL) will be assessed using the questionnaires SF 36, MacNew and Florida Patient Acceptance Survey", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "the secondary endpoint Device Revision/Replacement will be recorded as electrode dislocation/revision, device revision for pocket hematoma, perforation, or infection, device exchange due to malfunction, battery exhaustion, other reason, or upgrade to dual chamber or CRT-D", 
                "measure": "Device Revision / Device Replacement", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }, 
            {
                "description": "the secondary endpoint \"Costs\" will be assessed using patient questionnaires to the German-speaking study sites, an extension to other participating countries will be decided during the study, the assessment of cost-effectiveness will be realised by comparing cost-results with regard to changes in QoL", 
                "measure": "Costs and Cost-Effectiveness", 
                "safety_issue": "No", 
                "time_frame": "one to four years"
            }
        ], 
        "source": "University Medical Center Goettingen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Medical Center Goettingen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2014"
    }
}